PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.91%
Revenue growth exceeding 1.5x Insurance - Life median of 7.62%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
33.91%
Gross profit growth exceeding 1.5x Insurance - Life median of 20.88%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-2.61%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-2.61%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
6.70%
Net income growth exceeding 1.5x Insurance - Life median of 3.35%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
6.69%
EPS growth of 6.69% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
6.71%
Diluted EPS growth of 6.71% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.04%
OCF growth of 25.04% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
25.04%
FCF growth of 25.04% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
408.27%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 69.54%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
74.95%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 39.13%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
10.35%
3Y revenue/share growth below 50% of Insurance - Life median of 25.33%. Jim Chanos would suspect a significant short-term erosion in competitiveness.
163.91%
OCF/share CAGR of 163.91% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
52.50%
OCF/share CAGR of 52.50% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
20.76%
3Y OCF/share growth of 20.76% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-0.56%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 40.41%. Seth Klarman might see a fundamental problem if peers maintain growth.
714.61%
5Y net income/share CAGR > 1.5x Insurance - Life median of 39.78%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
202.23%
3Y net income/share CAGR of 202.23% while Insurance - Life median is zero. Walter Schloss might see a small advantage that can be scaled further.
92.97%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
24.68%
5Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier sees subpar net worth creation vs. competitors.
25.02%
3Y equity/share CAGR 50-75% of Insurance - Life median. Guy Spier suspects suboptimal short-term capital usage vs. peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.82%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
0.45%
Below 50% of Insurance - Life median. Jim Chanos suspects stagnation or limited capital availability for expansions.
-1.63%
Negative BV/share change while Insurance - Life median is 2.30%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-2.64%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
6.21%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.